The Iliac/SFA/Popliteal Center

Filter Your Results




Royal Philips to Acquire Spectranetics Corporation

June 28, 2017 -- Royal Philips and Spectranetics Corporation announced that they have entered into a definitive merger agreement. Philips will tender offers to shareholders fo…

One-Year CONSEQUENT Data Published for B. Braun's SeQuent Please Over-the-Wire DCB

June 28, 2017 -- The 6- and 12-month angiographic and clinical outcomes from the CONSEQUENT trial were published by Gunnar Tepe, MD, et al online in CardioVascular and Interve…

Medtronic's In.Pact Admiral DCB Approved for Reimbursement in France and Belgium

June 9, 2017 -- Medtronic announced the recent reimbursement approvals in France and Belgium for its In.Pact Admiral peripheral drug-coated balloon (DCB) for the treatment of …

ISAR-STATH Compares Interventional Treatments of SFA Disease

June 6, 2017 -- Findings from the ISAR-STATH trial were published by Ilka Ott, MD, et al in Circulation (2017;135:2218 -- 2226). ISAR-STATH is a randomized comparison of pa…

Evaluating the Legflow Device in the LEG-DEB Registry

Eugenio Stabile, MD, PhD

May 2017—A new generation of DCBs could achieve superiority in treating BTK arteries.

VascuFlex® Multi-LOC: Spot Stenting With SeQuent® Please OTW DCB

Klaus Amendt, MD, and Ralf Langhoff, MD

May 2017—Realizing the concept of leave-less-behind after DCB angioplasty in atherosclerotic lesions of the femoropopliteal artery.

PRELUDE Enrollment Completed for Cagent Vascular's Serranator Alto PTA Device

June 5, 2017 -- Cagent Vascular announced the completion of enrollment in the first-in-human PRELUDE study of the company's Serranator Alto percutaneous transluminal angio…

First-in-Human Study of Med Alliance's Selution DCB Completes Enrollment

May 30, 2017 -- Med Alliance Group, Inc., a Switzerland-based company, announced completion of patient enrollment in the first-in-human (FIH) evaluation of the Selution siroli…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.